Novo Nordisk A/S (NVO)

36.73 -1.03 (-2.73%) USD  |  NYSE  |  Mar 03, 13:48
More

Novo Nordisk Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
DBV Technologies SA Upgrade